Overall Technical outlook

Price Summary

On 2025-10-17, NATCOPHARM's stock started at 824.9, reached a high of 847.9, fell to 815.45, and ended 0.16% up at 826.2, with 901530 shares traded.
In the past year, the highest stock price was 1492.0, and the lowest was 746.5.
NATCOPHARM's future price is expected to lie between 710.0 and 1480.0, with an average expectation of 997.9091, as per the recommendations of 11 analysts.

Technicals

Support and Resistance: At 826.2, the price is supported by 809.6 and resisted by 841.25. This indicates that the price for NATCO Pharma Limited might fluctuate between these levels, with 809.6 acting as a support and 841.25 limiting further upward movement.
NATCOPHARM supportResistance 8f9c6b
Support/Resistance for NATCOPHARM


Aroon: The AROON is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
NATCOPHARM aroon 8f9c6b
Aroon chart for NATCO Pharma Limited


Bol. Bands: The BOLL BANDS is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
NATCOPHARM bbands 8f9c6b
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR remains bullish, establishing a key support level that could help uphold the market's upward trajectory. This persistent bullish outlook suggests that the market may continue to rise, with the support providing a foundation for further gains.
NATCOPHARM psar 8f9c6b
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The STOCHASTIC is showing a neutral stance, with no definitive indication of an upward or downward trend for NATCOPHARM. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
NATCOPHARM stoch 8f9c6b
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The moving averages for the 20-50-100 periods point to a bullish trend for NATCOPHARM, though the slopes of the faster averages suggest that this strength may be waning. The potential for a reversal is becoming evident, as the shorter-term averages indicate that the current upward momentum could be losing steam.
NATCOPHARM trippleSMA 8f9c6b
Tripple SMA chart for NATCO Pharma Limited


Understanding a company's fundamentals—such as revenue, earnings, and debt levels—provides a solid foundation for analyzing its technical performance. Similarly, knowledge of the industry, including key competitors and market trends, is critical. Combining this fundamental analysis with technical indicators like stock charts, moving averages, and trading volume enables a more comprehensive approach to evaluating the company's overall health and potential future performance.